# Intake review receipt

The completed ChatGPT review in the user-designated review conversation evaluated commit `f7e10ed` and approved freezing data intake eligibility for the 26 GSE254249 samples. This is not a GitHub platform approval or human authorization to execute analysis.

| Scope | Samples | Intake status |
| --- | ---: | --- |
| GSE254249 | 26 | approved |
| GSE236581 Tumor | 23 | pending |
| GSE236581 Normal | 4 | not approved |

Only the 26 GSE254249 `review_status` values have changed from `pending_final_review` to `approved`. Every `enabled` remains `0`; `EXECUTE_NMF=0`. No NMF, CNV, QC rerun, core algorithm change, or Git history rewrite was performed.

Approval relies on original `group=Cancer`, tumor-source metadata, and the identity collision check across all 92 source samples. Malignancy was not independently CNV-validated; unrecorded technical duplicates and cross-study patient identity remain unresolved. The c91 classification method remains unverified, historical results are not approved for direct reuse, and historical privacy governance remains OPEN. Private patient linkage is retained only on Argos.

Review conversation: https://chatgpt.com/g/g-p-68d69bbe15f48191bfd739a4ff18aa3d-tweakr-oncofetal/c/6ac946be-39f4-83e9-9ae7-4c281f804e84
